Disease management
![[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan](/sites/mhn/files/styles/230x130/public/2025-07/%2528Left%2529%2520Ed%2520Deng%252C%2520Co-founder%2520and%2520CEO%2520of%2520Health2Sync%2520and%2520%2528Right%2529%2520Claudio%2520Longo%252C%2520President%2520of%2520AstraZeneca%2520Taiwan.jpg?itok=XO7M1UnC)
Health2Sync has upgraded its patient management platform to identify patients' CKD risk levels.
This marks the urinalysis and wound-care company's third 510(k) clearance.
Also, MedleyMed launches its virtual clinic concept.
It has been approved as a prescription-only software-as-a-medical device in the US.
They have so far developed AI prediction models for breast, colon, and lung cancers.
The company has received backing from the state government of Western Australia.
Happify Health chief strategy officer Chris Wasden discusses the company's partnership strategy, the business environment for digital therapeutics and how to encourage physician uptake.
Fujifilm Thailand supports this implementation using Microsoft Azure.
Also, I-MED will expand its deployment of 4DMedical's lung imaging tool across its network in Australia.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.